weight loss drug news today glp-1 october 2025 New Daily Pill Aims to Take on Ozempic A New Medicare Option for

Using the efficacy estimand (treatment-adherent analysis), the 36 mg dose achieved 12.4% average weight loss, equivalent to approximately 27.3 pounds

Following are a few among them

As GLP-1 therapy improves glucose control, this osmotic effect typically diminishes, potentially normalising previously excessive urination patterns

The longest period in which conclusions on PDAC incidence after drug usage were made was seven years, which was a population-based cohort study 42

In the US, only 5% of adults meet the daily requirement of fibre intake, with the average consumption half the recommended amount

Your prescribed dose depends on multiple factors including your current HbA1c, body weight, renal function, other medications, and treatment goals